Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 850831, 6 pages
http://dx.doi.org/10.1155/2014/850831
Review Article

Respiratory Syncytial Virus Infections in Infants Affected by Primary Immunodeficiency

1Pediatrics and Neonatology Unit, Imola Hospital, Via Montericco 4, 40026 Imola, Italy
2DIMEC, Neonatology and Neonatal Intensive Care Unit, St. Orsola-Malpighi Hospital, Via Massarenti 11, University of Bologna, 40138 Bologna, Italy
3DIMES, Clinical Microbiology Unit, Laboratory of Virology, St. Orsola-Malpighi Hospital, Via Massarenti 9, University of Bologna, Bologna, Italy

Received 5 May 2014; Revised 11 June 2014; Accepted 12 June 2014; Published 25 June 2014

Academic Editor: Roshini Sarah Abraham

Copyright © 2014 Marcello Lanari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [20 citations]

The following is the list of published articles that have cited the current article.

  • M Boukhvalova, J C G Blanco, A R Falsey, and J Mond, “Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus,” Bone Marrow Transplantation, 2015. View at Publisher · View at Google Scholar
  • Jordan S. Orange, Wei Du, and Ann R. Falsey, “Therapeutic Immunoglobulin Selected for High Antibody Titer to RSV also Contains High Antibody Titers to Other Respiratory Viruses,” Frontiers in Immunology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Lourdes Arruvito, Silvina Raiden, and Jorge Geffner, “Host response to respiratory syncytial virus infection,” Current Opinion in Infectious Diseases, vol. 28, no. 3, pp. 259–266, 2015. View at Publisher · View at Google Scholar
  • Lina Bollani, Eugenio Baraldi, Gaetano Chirico, Andrea Dotta, Marcello Lanari, Antonello Del Vecchio, Paolo Manzoni, Antonio Boldrini, Piermichele Paolillo, Sandra Di Fabio, Luigi Orfeo, Mauro Stronati, and Costantino Romagnoli, “Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV),” Italian Journal of Pediatrics, vol. 41, no. 1, 2015. View at Publisher · View at Google Scholar
  • Yuki Chiba, Tomoh Matsumiya, Tsugumi Satoh, Ryo Hayakari, Ken Furudate, Fei Xing, Hidemi Yoshida, Kunikazu Tanji, Hiroki Mizukami, Tadaatsu Imaizumi, and Etsuro Ito, “Retinoic acid-inducible gene-I-like receptor (RLR)-mediated antiviral innate immune responses in the lower respiratory tract: Roles of TRAF3 and TRAF5,” Biochemical and Biophysical Research Communications, vol. 467, no. 2, pp. 191–196, 2015. View at Publisher · View at Google Scholar
  • José Eduardo Vargas, Ana Paula Duarte de Souza, Bárbara Nery Porto, Tiago Fazolo, Fabiana Quoos Mayer, Paulo Márcio Pitrez, and Renato Tetelbom Stein, “Immunomodulator plasmid projected by systems biology as a candidate for the development of adjunctive therapy for respiratory syncytial virus infection,” Medical Hypotheses, 2015. View at Publisher · View at Google Scholar
  • Silvia Vandini, Paolo Bottau, Giacomo Faldella, and Marcello Lanari, “Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus,” BioMed Research International, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Francesca Santini, “Human respiratory syncytial virus and Th1 chemokines,” Clinica Terapeutica, vol. 166, no. 3, pp. 203–208, 2015. View at Publisher · View at Google Scholar
  • Ashley Teusink-Cross, Stella M Davies, Lara Danziger-Isakov, Javier El-Bietar, and Michael S Grimley, “Restrictive palivizumab use does not lead to increased morbidity and mortality in pediatric hematopoietic stem cell transplant patients,” Biology of Blood and Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • Andreas Engert, Tony Green, Fleur De Haas, Achille Iolascon, Thierry Jaffredo, Francesco Rodeghiero, Gilles Sall Es, Jan Jacob Schuringa, Carlo Balduini, Anneke Brand, Bertrand Coiffier, Catherine Cordonnier, Hartmut Döhner, Thom Duyvené De Wit, Sabine Eichinger, and Willem Fibbe, “The european hematology association roadmap for european hematology research: A consensus document,” Haematologica, vol. 101, no. 2, pp. 115–208, 2016. View at Publisher · View at Google Scholar
  • Salem Al-Tamemi, Shafiq Ur Rehman Naseem, Nabila Al-Siyabi, Ibtisam El-Nour, Abdulhakim Al-Rawas, and David Dennison, “Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital,” Journal of Clinical Immunology, 2016. View at Publisher · View at Google Scholar
  • Silvia Vandini, Carlotta Biagi, and Marcello Lanari, “Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection,” International Journal of Molecular Sciences, vol. 18, no. 8, pp. 1717, 2017. View at Publisher · View at Google Scholar
  • Melanie A. Ruffner, Kathleen E. Sullivan, and Sarah E. Henrickson, “Recurrent and Sustained Viral Infections in Primary Immunodeficiencies,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Richard L. Wasserman, Benjamin N. Greener, and James Mond, “RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations,” Expert Review of Clinical Immunology, pp. 1–13, 2017. View at Publisher · View at Google Scholar
  • Ian Mitchell, Isabelle Defoy, and ElizaBeth Grubb, “Burden of Respiratory Syncytial Virus Hospitalizations in Canada,” Canadian Respiratory Journal, vol. 2017, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Olga Chatzis, Stephanie Darbre, Jérôme Pasquier, Pascal Meylan, Oriol Manuel, John David Aubert, Maja Beck-Popovic, Stavroula Masouridi-Levrat, Marc Ansari, Laurent Kaiser, Klara M. Posfay-Barbe, and Sandra A. Asner, “Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study,” BMC Infectious Diseases, vol. 18, no. 1, 2018. View at Publisher · View at Google Scholar
  • Anna C. Vittucci, Paola Zangari, Claudia Ciarlitto, Chiara Di Camillo, Annalisa Grandin, Nicola Cotugno, Maria R. Marchili, and Alberto Villani, “Active prophylaxis for respiratory syncytial virus: current knowledge and future perspectives,” Minerva Pediatrica, vol. 70, no. 6, 2018. View at Publisher · View at Google Scholar
  • Virginia Mirra, Nicola Ullmann, Claudio Cherchi, Alessandro Onofri, Maria G. Paglietti, and Renato Cutrera, “Respiratory syncytial virus prophylaxis and the "special population",” Minerva Pediatrica, vol. 70, no. 6, 2018. View at Publisher · View at Google Scholar
  • C. Ciarlitto, A. C. Vittucci, L. Antilici, C. Concato, C. Di Camillo, P. Zangari, and A. Villani, “Respiratory Syncityal Virus A and B: three bronchiolitis seasons in a third level hospital in Italy,” Italian Journal of Pediatrics, vol. 45, no. 1, 2019. View at Publisher · View at Google Scholar
  • Carrie-Anne Malinczak, Wendy Fonseca, Andrew J. Rasky, Catherine Ptaschinski, Susan Morris, Steven F. Ziegler, and Nicholas W. Lukacs, “Sex-associated TSLP-induced immune alterations following early-life RSV infection leads to enhanced allergic disease,” Mucosal Immunology, 2019. View at Publisher · View at Google Scholar